Subclinical Persistent Inflammation as Risk Factor for Crohn's Disease Progression: Findings From a Prospective Real-World Study of 2 Years

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

Erik von Elm, Douglas G. Altman, Matthias Egger et al. · The Lancet · 2007 · 18.7K citations · Full text

Public Health, Public Health Practice, Epidemiologic Methods +10

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

Jack Satsangi · Gut · 2006 · 3.2K citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications

Christian Maaser, Andreas Sturm, Stephan R. Vavricka et al. · Journal of Crohn s and Colitis · 2018 · 1.8K citations · Full text

Medicine, Clinical Sciences, Internal Medicine +9

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

Jean‐Frédéric Colombel, Remo Panaccione, Peter Bossuyt et al. · The Lancet · 2017 · 912 citations

Medicine, Internal Medicine, Gastroenterology +3

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

Geert D’Haens, Marc Ferrante, Séverine Vermeire et al. · Inflammatory Bowel Diseases · 2012 · 811 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17